Top line decelerating.
+11.2% YoY versus +26.6% prior. 3y CAGR +15.1%.
+11.2%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $78.8B
Live price unavailable
Fundamentals as of 2025-12-31
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
Bottom line: CI is rated BUY by the 1 legendary model, but earns a C sector grade (47/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
Concerns — Cigna Corporation's 14.3% ROE is below sector median.
Financial story
Concerns — Cigna Corporation's 14.3% ROE and 2.78 debt-to-equity warrant a closer look at the underlying business.
CI is in the Healthcare sector. Sector ranking and peer comparison are in the sector tab.
0 of 6 legendary investor models rate CI a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
Cigna Corporation's fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
CI trades at 12.2x earnings. Sector context and per-investor signals are in the valuation tab.
CI and REGN differ on P/E, ROE, and revenue growth. See the full CI vs REGN compare matrix.
Buffett evaluates CI against his respective frameworks. Per-model fair value and reasoning are in the valuation tab.
How does CI compare?
See exactly where CI ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingCI sits at #66 in Healthcare with a C grade (47/100).